以自身免疫性溶血性贫血起病的华氏巨球蛋白血症1例并文献复习
被引量:3
摘要
目的:提高对华氏巨球蛋白血症(WM)的认识水平。方法:报告1例WM患者的临床表现及实验室检查,并进行相关文献复习,为诊断和治疗提供思路。结果:患者骨髓涂片示浆细胞样淋巴细胞占12.50%,血清单克隆IgM最高达91.50g/L、直接抗人球蛋白试验阳性、无骨质破坏。结论:该例明确诊断为WM。骨髓涂片见浆细胞样淋巴细胞、血清中单克隆IgM>10g/L、无骨质破坏并结合临床表现可诊断WM。
出处
《临床血液学杂志》
CAS
2010年第4期421-423,共3页
Journal of Clinical Hematology
参考文献16
-
1DIMOPOULOS M A,GERTZ M A,KASTRITIS E,et al.Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia[J].J Clin Oncol,2009,27:120-126.
-
2ARSLAN O,ARAT M,TEK I,et al.Therapeutic plasma exchange in a single center:Ibni Sina experience[J].Transfus Apher Sci,2004,30:181-184.
-
3DHODAPKAR M V,JACOBSON J L,GERTZ M A,et al.Prognostic factors and response to fludarabine therapy in Waldenstrm's macroglobulinemia:an update of a US intergroup trial (SWOG S9003)[J].Semin Oncol,2003,30:220-225.
-
4FORAN J M,ROHATINER A Z,COIFFIER B,et al.Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma,Waldenstrm's macroglobulinemia,and mantle-cell lymphoma[J].J Clin Oncol,1999,17:546-553.
-
5WEBER DONNA M,DIMOPOULOS MELETIOS A,DELASALLE K,et al.2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia[J].Semin Oncol,2003,30:243-247.
-
6DIMOPOULOS M A,WEBER D M,KANTARJIAN H,et al.2-Chlorodeoxyadenosine therapy of patients with Waldenstrm macroglobulinemia previously treated with fludarabine[J].Ann Oncol,1994,5:288-289.
-
7KYLE R A,GREIPP P R,GERTZ M A,et al.Waldenstrom's macroglobulinaemia:a prospective study comparing daily with intermittent oral chlorambucil[J].Br J Haematol,2000,108:737-742.
-
8RODRIGUEZ J N,FERNANDEZ-JURADO A,MARTINO M L,et al.Waldenstrom's macroglobulinemia complicated with acute myeloid leukemia.Report of a case and review of the literature[J].Haematologica,1998,83:91-92.
-
9DIMOPOULOS M A,ZERVAS C,ZOMAS A,et al.Extended rituximab therapy for previously untreated patients with Waldenstrom's macroglobulinemia[J].Clin Lymphoma,2002,3:163-166.
-
10GERTZ M A,RUE M,BLOOD E,KAMINER L S,et al.Multicenter phase 2 trial of rituximab for Waldenstrom macroglobulinemia (WM):an Eastern Cooperative Oncology Group Study (E3A98)[J].Leuk Lymphoma,2004,45:2047-2055.
同被引文献42
-
1任昊.肾性贫血[J].实用医学杂志,2007,23(5):768-769. 被引量:8
-
2Birgeggtrd G. Managing anemia in lymphoma and multiple myeloma. Ther Clin Risk Manag,2008,4:527-539.
-
3Kyle RA, Rajkumar SV. Multiple myeloma. Blood 2008, 111:2962 -2972.
-
4Caravita T, Siniscalchi A, Montanaro M, et al. High-dose epoetin alfa as induction treatment for severe anemia in multiple myeloma patients. Int J Hematol,2009,90:270-272.
-
5Silvestris F, Cafforio P, Tucci M, et al. Negative regulation of eirthroblast maturation by Fas-L ( + )/TRAIL ( + ) highly malignant plasma cells : a major pathogenetic mechanism of anemia in muhiple myeloma. Blood,2002, 99 : 1305-1313.
-
6Silvestris F, Tucci M, Cafforio P, et al. Fas-L up-regulation by highly malignant myeloma plasma cells : role in the pathogenesis of anemia and disease progression. Blood, 2001,97:1155-1164.
-
7Cucuianu A, Patiu M, Rusu A, et al. Hepcidin and multiple myeloma related anemia. Med Hypotheses ,2006,66:352-354.
-
8Balogh A, Bosze S, Horvgtti K, et al. Role of iron metabolism- regulator hepcidin in perinatal iron homeostasis. Or,: Hefil,2010, 151:83-91.
-
9De Domenico I, Ward DM, Kaplan J, et al. Hepeidin and ferroportin: the new players in iron metabolism. Semin Liver Dis, 2011,31 : 272-279.
-
10Sharma S, Nemelh E, Chen YH, et at. Involvement of hepcidin in the anemia of multiple myeloma. Clin Cancer Res ,2008,14:3262- 3267.
引证文献3
-
1梅舒翀,王化泉,邵宗鸿.多发性骨髓瘤贫血机制的研究进展[J].中华医学杂志,2013,93(20):1594-1596. 被引量:8
-
2张晓娟,杜伟,郭树霞,陈荣华.相继发生的温抗体型自身免疫性溶血性贫血、冷凝集素综合征及IgM型多发性骨髓瘤1例并文献复习[J].临床血液学杂志,2015,28(2):244-246. 被引量:3
-
3郭海飞,吴丽丽,冯爱梅,赵朴.华氏巨球蛋白血症2例及文献复习[J].浙江实用医学,2017,22(4):308-309. 被引量:1
二级引证文献12
-
1王强生,汪延生,丁士华,陈礼文,袁靖中,桂前乐,秦慧.血清铁调素测定在多发性骨髓瘤中的临床意义[J].安徽医学,2016,37(6):669-671. 被引量:2
-
2何牧卿,何牧群,郭文坚.多发性骨髓瘤患者医院感染原因分析与控制[J].中华全科医学,2015,13(5):746-747. 被引量:4
-
3刘铮,李燕,刘凤奎.全身酸痛伴血钙增高[J].中国医刊,2016,51(1):14-16. 被引量:4
-
4余柳翠.自身免疫性溶血性贫血患者交叉配血不合与试验研究[J].中西医结合心血管病电子杂志,2016,4(26):23-24. 被引量:1
-
5石磊,骆志成,王慧,张明昕.血细胞多参数联合分析在大细胞性贫血疾病中的诊断价值[J].标记免疫分析与临床,2017,24(11):1221-1224. 被引量:16
-
6陈优优,蒋慧芳,陶叠宏,苏传勇,郭淑萍,吴海英,吴元庭.多发性骨髓瘤伴纯红细胞再生障碍性贫血一例并文献复习[J].浙江中西医结合杂志,2019,29(2):155-157. 被引量:1
-
7姜倩倩,吴小燕,王白莹.多发性骨髓瘤合并肾损伤患者的临床特点及危险因素分析[J].中华肾脏病杂志,2020,36(2):123-130. 被引量:18
-
8王亚茹,马艳萍.以冷凝集素综合征为首发表现的多发性骨髓瘤患者的早期诊断[J].中国实验血液学杂志,2021,29(3):787-790. 被引量:6
-
9顾晓雯,孙舒君.多发性骨髓瘤患者口腔卫生环境调查及与微炎症、营养状态的相关性研究[J].解放军医药杂志,2021,33(7):15-18. 被引量:3
-
10俞玲.多发性骨髓瘤患者肾损伤预测模型的构建[J].广东医学,2021,42(7):802-805. 被引量:7
-
1刘艳奎,庄秀琴.以鼻衄为首发表现的华氏巨球蛋白血症1例[J].现代预防医学,2009,36(16):3198-3198. 被引量:1
-
2胡桂华,朱小东.华氏巨球蛋白血症一例分析[J].医疗装备,2013,26(6):40-41.
-
3张田.华氏巨球蛋白血症1例报告[J].锦州医学院学报,2002,23(5):77-77.
-
4王晓燕,杨仁池.华氏巨球蛋白血症的治疗进展[J].国际输血及血液学杂志,2006,29(2):154-157. 被引量:3
-
5朱小东,胡桂华,谢志雄,徐忠玉.华氏巨球蛋白血症1例[J].国际检验医学杂志,2014,35(22):3151-3151. 被引量:1
-
6陈婷,张曦,张诚,刘耀,高蕾,高力,文钦,罗晓庆,陈幸华.美罗华治疗老年自身免疫性溶血性贫血的临床研究[J].国际检验医学杂志,2011,32(11):1199-1199. 被引量:6
-
7田婷.急性心肌梗死合并急性胆囊炎及溶血性贫血1例分析[J].中国误诊学杂志,2011,11(28):7011-7011.
-
8张彦萍,马俊义,吴雅丽.以急性溶血性贫血为首发表现的艾滋病1例[J].临床荟萃,2005,20(16):948-948.
-
9于远军,张敏.华氏巨球蛋白血症骨髓细胞学诊断[J].临床血液学杂志(输血与检验),2017,30(1):150-151. 被引量:1
-
10金凤钟,刘艳,薛明涛,王晓明,宁晓暄.以肾病综合征为首发表现的华氏巨球蛋白血症1例[J].中华老年多器官疾病杂志,2015,14(3):229-230. 被引量:1